
Pretreatment with Lactobacillus fermentum XY18 Relieves Gastric Injury Induced by HCl/Ethanol in Mice via Antioxidant and Anti-Inflammatory Mechanisms
Author(s) -
Ranran Wang,
Kailiang Zhou,
Rongrong Xiong,
Yi Yang,
Ruokun Yi,
Jing Hu,
Wei Liao,
Xin Zhao
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s280429
Subject(s) - lactobacillus fermentum , nitric oxide , chemistry , malondialdehyde , glutathione , superoxide dismutase , pharmacology , glutathione peroxidase , nitric oxide synthase , antioxidant , myeloperoxidase , medicine , endocrinology , biochemistry , lactic acid , inflammation , biology , lactobacillus plantarum , enzyme , bacteria , genetics
Lactobacillus fermentum XY18 (LF-XY18) is a bacterial strain with satisfactory antioxidant properties in vitro that we previously isolated from Xinjiang yogurt. This article will explore the preventive effect of LF-XY18 on acute gastric injury and provide the basis for the innovative development and application of lactic acid bacteria (LAB).